NLM Logo

Rituximab MeSH Descriptor Data 2022


MeSH Heading
Rituximab
Tree Number(s)
D12.776.124.486.485.114.224.075.785
D12.776.124.790.651.114.224.075.785
D12.776.377.715.548.114.224.284.785
Unique ID
D000069283
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069283
Scope Note
A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.
Entry Term(s)
CD20 Antibody, Rituximab
GP2013
IDEC-C2B8
IDEC-C2B8 Antibody
Mabthera
Rituxan
Pharm Action
Antineoplastic Agents, Immunological
Immunologic Factors
Antirheumatic Agents
Registry Number
4F4X42SYQ6
Related Numbers
174722-31-7
See Also
Antigens, CD20
Public MeSH Note
2016; RITUXIMAB was indexed under ANTIBODIES, MONOCLONAL, MURINE-DERIVED 1995-2016
History Note
2016 (1995)
Date Established
2016/01/01
Date of Entry
2015/07/01
Revision Date
2020/05/27
Rituximab Preferred
Mabthera Narrower
IDEC-C2B8 Antibody Narrower
GP2013 Narrower
Rituxan Narrower
page delivered in 0.15s